Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2010
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010083384A9 Non-peptidyl, potent, and selective mu opioid receptor antagonists
10/14/2010US20100261815 Photoactive compound and photosensitive resin composition comprising the same
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2757963A1 Hepatitis c virus inhibitors
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2757269A1 Hepatitis c virus inhibitors
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2239254A1 Benzylpiperizine compound
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238130A1 Carboxamide compounds and their use as calpain inhibitors
10/13/2010EP2238129A1 A method for the preparation of darifenacin hydrogen bromide
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1204642B1 Fungicides
10/13/2010CN201603544U 异氰尿酸三缩水甘油脂熔融造粒装置 Isocyanurate three glycidyl melt granulation plant
10/13/2010CN101861312A 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-HT7 receptor antagonists
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101857557A Compound and preparation method thereof and midbody compound prepared with same and preparation method thereof
10/13/2010CN101856623A Phenylpropyl-12-crown-4imidazole carbene catalyst and preparation method and application thereof
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/12/2010US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses
10/12/2010US7812178 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors
10/12/2010US7812170 Insecticides
10/12/2010US7812160 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812036 Androgens
10/12/2010US7812031 Pyrimidine derivatives as orexin receptor antagonists
10/12/2010CA2477903C Substituted benzofurans useful as protein kinase b activators
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/07/2010WO2010113986A1 Use of pyridazinone compound for control of harmful arthropod pests
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112488A1 Method for obtaining 1,3-difunctionalized pyrrolidine derivatives
10/07/2010US20100256370 Process for the Preparation of Alfuzosin Hydrochloride
10/07/2010US20100256216 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256113 Quinolone derivative
10/07/2010US20100255504 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757188A1 Pyrimidine compound
10/06/2010EP2236509A1 Method for obtaining 1,3-difunctionalized pyrrolidine derivatives
10/06/2010EP2236508A1 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/06/2010EP2236500A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2235007A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
10/06/2010EP2235006A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2235005A2 Azolylmethyloxiranes, use thereof and agents containing the same
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010CN1829512B Medicinal composition containing triazole compound
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN101855218A Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
10/06/2010CN101855214A Benzimidazole derivatives and their use as FXR agonists
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/06/2010CN101851196A 2-(1H) quinolinone derivative, medical composition, preparation method and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807845 Enzyme inhibitor for treating HIV infections; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy; {1-Benzyl-3-[(3-dimethylaminomethylene-2-oxo-2,3-dihydro-1H-indole-5-sulfonyl)-isobutyl-amino]-2-hydroxy-propyl}-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807672 Compounds that are ERK inhibitors
10/05/2010US7807670 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010CA2440839C Sulfoxides or sulfones grafted onto polymers
10/05/2010CA2400479C Platelet adp receptor inhibitors
10/05/2010CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111572A1 Compounds as cannabinoid receptor ligands
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 694